393 related articles for article (PubMed ID: 17486276)
1. Expression of Nkx3.1 enhances 17beta-estradiol anti-tumor action in PC3 human prostate cancer cells.
Wang P; Liu B; Luo JD; Zhang ZG; Ma Q; Chen ZD
Asian J Androl; 2007 May; 9(3):353-60. PubMed ID: 17486276
[TBL] [Abstract][Full Text] [Related]
2. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
[TBL] [Abstract][Full Text] [Related]
3. NKX3.1 potentiates TNF-alpha/CHX-induced apoptosis of prostate cancer cells through increasing caspase-3 expression and its activity.
Pengju Z; Weiwen C; Aiying W; Zhaobo C; Nana N; Zhaoqin H; Qingwei L; Anli J
Biochem Biophys Res Commun; 2010 Jul; 398(3):457-61. PubMed ID: 20599703
[TBL] [Abstract][Full Text] [Related]
4. A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. I: In vitro studies.
Li L; Zhu Z; Joshi B; Porter AT; Tang DG
Anticancer Res; 1999; 19(1A):51-60. PubMed ID: 10226524
[TBL] [Abstract][Full Text] [Related]
5. Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer.
Xu LL; Srikantan V; Sesterhenn IA; Augustus M; Dean R; Moul JW; Carter KC; Srivastava S
J Urol; 2000 Mar; 163(3):972-9. PubMed ID: 10688034
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of NKX3.1 in LNCaP prostate cancer cells by RNA interference.
Possner M; Heuser M; Kaulfuss S; Scharf JG; Schulz W; Hermann-Ringert R; Thelen P
Int J Oncol; 2008 Apr; 32(4):877-84. PubMed ID: 18360715
[TBL] [Abstract][Full Text] [Related]
7. Reduced tumor growth in vivo and increased c-Abl activity in PC3 prostate cancer cells overexpressing the Shb adapter protein.
Davoodpour P; Landström M; Welsh M
BMC Cancer; 2007 Aug; 7():161. PubMed ID: 17697368
[TBL] [Abstract][Full Text] [Related]
8. The inhibitory effects of NKX3.1 on IGF-1R expression and its signalling pathway in human prostatic carcinoma PC3 cells.
Zhang PJ; Hu XY; Liu CY; Chen ZB; Ni NN; Yu Y; Yang LN; Huang ZQ; Liu QW; Jiang AL
Asian J Androl; 2012 May; 14(3):493-8. PubMed ID: 22179513
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of the homeobox gene NKX3.1 by all-trans retinoic acid in prostate cancer cells.
Thomas MA; Hodgson MC; Loermans SD; Hooper J; Endersby R; Bentel JM
J Cell Biochem; 2006 Dec; 99(5):1409-19. PubMed ID: 16817226
[TBL] [Abstract][Full Text] [Related]
10. Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3' untranslated region.
Thomas MA; Preece DM; Bentel JM
Biochem J; 2010 Jan; 425(3):575-83. PubMed ID: 19886863
[TBL] [Abstract][Full Text] [Related]
11. Zyflamend inhibits the expression and function of androgen receptor and acts synergistically with bicalutimide to inhibit prostate cancer cell growth.
Yan J; Xie B; Capodice JL; Katz AE
Prostate; 2012 Feb; 72(3):244-52. PubMed ID: 21656835
[TBL] [Abstract][Full Text] [Related]
12. Prostate androgen-regulated gene: a novel potential target for androgen-independent prostate cancer therapy.
Xu XF; Zhou SW; Zhang X; Ye ZQ; Zhang JH; Ma X; Zheng T; Li HZ
Asian J Androl; 2006 Jul; 8(4):455-62. PubMed ID: 16763722
[TBL] [Abstract][Full Text] [Related]
13. Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells.
Yu CH; Kan SF; Pu HF; Jea Chien E; Wang PS
Cancer Sci; 2008 Dec; 99(12):2467-76. PubMed ID: 19037992
[TBL] [Abstract][Full Text] [Related]
14. Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer.
Asatiani E; Huang WX; Wang A; Rodriguez Ortner E; Cavalli LR; Haddad BR; Gelmann EP
Cancer Res; 2005 Feb; 65(4):1164-73. PubMed ID: 15734999
[TBL] [Abstract][Full Text] [Related]
15. The role of serotonin (5-hydroxytryptamine1A and 1B) receptors in prostate cancer cell proliferation.
Siddiqui EJ; Shabbir M; Mikhailidis DP; Thompson CS; Mumtaz FH
J Urol; 2006 Oct; 176(4 Pt 1):1648-53. PubMed ID: 16952708
[TBL] [Abstract][Full Text] [Related]
16. Mahanine inhibits growth and induces apoptosis in prostate cancer cells through the deactivation of Akt and activation of caspases.
Sinha S; Pal BC; Jagadeesh S; Banerjee PP; Bandyopadhaya A; Bhattacharya S
Prostate; 2006 Sep; 66(12):1257-65. PubMed ID: 16683271
[TBL] [Abstract][Full Text] [Related]
17. Curcumin downregulates homeobox gene NKX3.1 in prostate cancer cell LNCaP.
Zhang HN; Yu CX; Zhang PJ; Chen WW; Jiang AL; Kong F; Deng JT; Zhang JY; Young CY
Acta Pharmacol Sin; 2007 Mar; 28(3):423-30. PubMed ID: 17303007
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway.
Zhang AL; Russell PJ; Knittel T; Milross C
Prostate; 2007 Nov; 67(15):1630-40. PubMed ID: 17823933
[TBL] [Abstract][Full Text] [Related]
19. The cannabinoid R+ methanandamide induces IL-6 secretion by prostate cancer PC3 cells.
Olea-Herrero N; Vara D; Malagarie-Cazenave S; Díaz-Laviada I
J Immunotoxicol; 2009 Dec; 6(4):249-56. PubMed ID: 19908944
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of cell death regulators in response to thapsigargin and adriamycin in Bcl-2 transfected DU145 prostatic cancer cells.
Chaudhary KS; Abel PD; Stamp GW; Lalani E
J Pathol; 2001 Apr; 193(4):522-9. PubMed ID: 11276013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
